IL1R2 and breast cancer: Interleukin-1 receptor type 2 (IL1R2) binds with, and enhances, USP15 to deubiquitinate BMI1at the K81 residue, thereby promoting the breast cancer cell lines SUM159 and MB231, as well as their proliferation and invasion [70].